Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00625365 · ClinicalTrials.gov registry record · Phase 4
A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice
A Phase 4 study, sponsored by Lantheus Medical Imaging.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,060
- Enrollment target
NCT00625365 is a Phase 4 study that has completed, run by Lantheus Medical Imaging. The registered enrollment target is 1,060 participants.
The verdict
NCT00625365, a Phase 4 study, has completed, sponsored by Lantheus Medical Imaging.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,060 participants
- Enrollment target
Study Summary
The purpose of this registry study is to gather safety information on the current clinical use of and the safety of DEFINITY®
Interventions
- DRUG DEFINITY®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,060 participants |
| Start Date | 2008-02 |
| Est. Completion | 2009-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00625365
The ClinicalTrials.gov registry entry for NCT00625365 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,060 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lantheus Medical Imaging, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DEFINITY® is the first listed.
NCT00625365 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00625365 about?
NCT00625365 is a clinical study titled "A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice". The purpose of this registry study is to gather safety information on the current clinical use of and the safety of DEFINITY®
What is the current status of trial NCT00625365?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,060 participants. The study started on 2008-02. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00625365?
The interventions under investigation include: DEFINITY® (DRUG).
Who is sponsoring clinical trial NCT00625365?
This trial is sponsored by Lantheus Medical Imaging, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.